NEU neuren pharmaceuticals limited

Ann: Comment on research report, page-316

  1. 6,343 Posts.
    lightbulb Created with Sketch. 22983
    Neuren has filed yet another Compositions of Trofinetide US patent application, with the latest application filed last November and only published last week.

    The first Compositions of Trofinetide US patent application was filed in June 2021 and granted in June 2022, the second, recently referred to by Sillazze, was filed in June 2022 and granted in January this year.

    United States of America
    Application Number 18516604
    Application Date 21.11.2023
    Publication Number 20240109841
    Publication Date 04.04.2024
    Publication Kind A1

    United States of America
    Application Number 17847736
    Application Date 23.06.2022
    Publication Number 20220324799
    Publication Date 13.10.2022
    Grant Number 11866406
    Grant Date 09.01.2024
    Publication Kind B2

    United States of America
    Application Number 17347135
    Application Date 14.06.2021
    Publication Number 20220055987
    Publication Date 24.02.2022
    Grant Number 11370755
    Grant Date 28.06.2022
    Publication Kind B2
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$17.78
Change
0.230(1.31%)
Mkt cap ! $2.240B
Open High Low Value Volume
$17.83 $17.99 $17.35 $16.12M 911.8K

Buyers (Bids)

No. Vol. Price($)
2 11000 $17.40
 

Sellers (Offers)

Price($) Vol. No.
$17.80 10070 2
View Market Depth
Last trade - 16.10pm 08/08/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.